As of 2025-07-03, the Intrinsic Value of Luminex Corp (LMNX) is 8.74 USD. This Luminex valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 36.99 USD, the upside of Luminex Corp is -76.4%.

The range of the Intrinsic Value is 6.64 - 13.54 USD.

Is Luminex undervalued or overvalued?

Based on its market price of 36.99 USD and our intrinsic valuation, Luminex Corp (LMNX) is overvalued by 76.4%.

36.99 USD

Stock Price

8.74 USD

Intrinsic Value

Intrinsic Value Details

Luminex Intrinsic Value - Valuation Summary

	Range	Selected	Upside
a
DCF (Growth Exit 5Y)	6.64 - 13.54	8.74	-76.4%
DCF (Growth Exit 10Y)	9.75 - 19.98	12.89	-65.1%
DCF (EBITDA Exit 5Y)	21.87 - 26.93	23.89	-35.4%
DCF (EBITDA Exit 10Y)	24.28 - 32.65	27.73	-25.0%
Peter Lynch Fair Value	2.48 - 2.48	2.48	-93.29%
P/E Multiples	13.44 - 21.1	14.92	-59.7%
EV/EBITDA Multiples	27.9 - 32.53	29.30	-20.8%
Earnings Power Value	7.27 - 9.83	8.55	-76.9%
Dividend Discount Model - Stable	4.12 - 11.83	7.97	-78.4%
Dividend Discount Model - Multi Stages	6.19 - 12.95	8.29	-77.6%

Luminex Intrinsic Value - Peers Comparison

	Range	Selected	Upside
a
Thermo Fisher Scientific Inc	400.15 - 1,042.77	585.20	36.8%
Agilent Technologies Inc	95.05 - 244.73	136.32	13.0%
Mettler-Toledo International Inc	851.2 - 3,205.78	1,348.58	11.9%
Waters Corp	255.7 - 887.01	394.48	12.1%
PerkinElmer Inc	74.75 - 347.87	131.72	14.3%
Qiagen NV	10.48 - 41.61	17.64	-63.7%
Bio-Techne Corp	28.42 - 86.71	42.49	-20.1%
Bruker Corp	29.73 - 129.21	51.90	22.2%
Biotage AB	54.34 - 212.98	83.58	-41.6%

Luminex Intrinsic Value - Key Valuation Metrics

Market Cap (mil)	1,750
Beta	0.57
Outstanding shares (mil)	47
Enterprise Value (mil)	1,732

Market risk premium	4.7%
Cost of Equity	8.15%
Cost of Debt	4.25%
WACC	7.6%